Androstenedione is the preferred androgen source in hormone refractory prostate cancer-Response

Christopher Hovens, Matthew Hong, Niall Corcoran

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)4972-4973
Number of pages2
JournalClinical Cancer Research
Volume20
Issue number18
DOIs
Publication statusPublished - 15 Sept 2014
Externally publishedYes

Cite this